Effects of the 21-aminosteroid U74389G in a model of chronic myocardial infarction in the rat

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 6, 1999, Pages 857-863

  Ngo, Phong Liem ^a   Chen, Huifang ^b   Qi, Shijie ^b   Paquette, France ^a   Dumont, Louis ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Campus Notre Dame   (Canada)

Author keywords

21 Aminosteroids; Cardioplegia; Contractility; Coronary flow; Endothelium; Myocardial infarction

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE;

ANIMAL EXPERIMENT; ARTICLE; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; BRADYKININ; CHRONIC DISEASE; COLD; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; HEART ARREST, INDUCED; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NITROPRUSSIDE; PREGNATRIENES; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 0032757338     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199912000-00013     Document Type: Article

References (48)

1. Prasad MR, Das DP. Effect of oxygen-derived free radicals and oxidants on the degradation in vitro of membrane and phospholipids. Free Radic Res Commun 1989;7:3-6.
2. Ytrehus K, Hegstad AC. Lipid peroxydation and membrane damage of the heart. Acta Physiol Scand 1991;S599:81-91.
3. Ambrosio G, Flaherty JT, Duillio C, et al. Oxygen radicals generated at reflow induce peroxydation of membrane lipids in reperfused hearts. J Clin Invest 1991;87:2056-66.
4. Reddy BR, Kloner RA, Przyklenk K. Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury. Free Radic Biol Med 1989;7:45-52.
5. Klein HH, Pich S, Lindert S, Nebendahl K, Niedman P, Kreuzer H. Combined treatment with vitamin E and C in experimental myocardial infarction in pigs. Am Heart J 1989;118:667-73.
6. Koerner JE, Anderson BA, Dage RC. Protection against postischemic myocardial dysfunction in anesthetized rabbits with scavengers of oxygen-derived free radicals superoxide dismutase plus catalase, N-2-mercaptoproprionyl glycine and captopril. J Cardiovasc Pharmacol 1991;17:185-91.
7. Pietri S, Culcasi M, Albat B, Alberici G, Menasché P. Direct assessment of the antioxidant effects of a new heart preservation solution, celsior. Transplantation 1994;58:739-42.
8. 10 of canine myocardial reperfusion injury after preservation. J Thorac Cardiovasc Surg 1992;103:945-51.
9. Maxwell SR. Prospects for the use of antioxidant therapies. Drugs 1995;49:345-61.
10. Braughler JM, Pregenzer JF, Chase RL, et al. Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxydation. J Biol Chem 1987;262:10438-40.
11. Jacobsen EJ, McCall JM, Ayer DE, et al. Novel 21-aminosteroids that inhibit iron-dependent lipid peroxydation and protect against central nervous system trauma. J Med Chem 1990;33:1145-51.
12. Taylor BM, Fleming WE, Benjamin CW, Wu Y, Mathews WR, Sun FF. The mechanism of cytoprotective action of lazaroids. I: inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion. J Pharmacol Exp Ther 1996;276:1224-31.
13. Vaziri ND, Ding Y, Ni Z, Gonick HC. Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: effect of lazaroid therapy. Kidney Int 1997;52: 1042-6.
14. Hall ED, McCall JM, Means ED. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol 1994;28:221-68.
15. Sadrzadeh SM, Nanji AA. The 21-aminosteroid 16-desmethyl tirilazad mesylate prevents necroinflammatory changes in experimental alcoholic liver disease. J Pharmacol Exp Ther 1998;284: 406-12.
16. Moreyra AE, Conway RF, Wilson AC, Chen WH, Schmidling MJ, Kostis JB. Attenuation of myocardial stunning in isolated rat hearts by a 21-aminosteroid lazaroid (U74389G). J Cardiovasc Pharmacol 1996;28:659-64.
17. Campo GM, Squadrito F, Altavilla D, et al. Protection of ischemic and reperfused rat myocardium by the nonglucocorticoid 21-aminosteroid U74389G: a new inhibitor of lipid peroxydation. J Pharmacol Exp Ther 1996;277:333-40.
18. Duguay P, Chen H, Daloze P, Dumont L. Cardioprotective effects of the lazaroid U74389G following cold preservation and transplantation of rat hearts. Transplantation 1996;61:1023-8.
19. Anversa P, Beghi C, Kikkawa Y, Olivetti G. Myocardial infarction in rats: infarct size, myocyte hypertrophy and capillary growth. Circ Res 1986;58:26-37.
20. Todo S, Hamada N, Zhu Y, et al. Lazaroid U-74389G for 48-hour canine liver preservation. Transplantation 1996;61:189-94.
21. Tanguay M, Lepage G, Blaise G, Garceau D, Dumont L. Clentiazem, diltiazem, and cold cardioplegia in isolated ischemic rabbit hearts: relation between additive cardioprotection, physicochemical properties, and preservation of myocardial lipid component. J Cardiovasc Phannacol 1994;24:950-9.
22. Vanden Hoek TL, Shao Z, Li C, Zak R, Schumacker PT. Reperfusion injury on cardiac myocytes after simulated ischemia. Am J Physiol 1996;270:H1334-41.
23. Flaherty JT. Myocardial injury mediated by oxygen free radicals. Am J Med 1991;91:79S-85S.
24. Yasmin W, Strynadka KD, Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res 1997;33:422-32.
25. Chandra M, Chandra N, Agrawal R, Kumar A, Ghatak A, Pandey VC. The free radical system in ischemic heart disease. Int J Cardiol 1994;43:121-5.
26. Qayumi AK, Jamieson WRE, Rosaldo LJ, Mcconville B, Chow VDW. Control of oxygen cytotoxicity with allopurinol and superoxide dismutase: a canine model of global myocardial ischemia-reperfusion injury. J Invest Surg 1997;10:63-8.
27. Tomoda H, Morimoto K, Aoki N. Superoxide dismutase activity as a predictor of myocardial reperfusion and salvage in acute myocardial infarction. Am Heart J 1996;131:849-56.
28. Zeidman SM, Ling GSF, Ducker TB, Ellenbogen RG. Clinical applications of pharmacologic therapies for spinal cord injury. J Spinal Dis 1996;9:367-80.
29. Natale JE, Schott RJ, Hall ED, Braughler JM, d'Alecy LG. Effects of the aminosteroid U74006F after cardiopulmonary arrest in dogs. Stroke 1988;19:1371-6.
30. Paroni R, De Vecchi E, Lubatti L, et al. Influence of the 21-aminosteroid U74389F on ischemia-reperfusion injury in the rat. Eur J Pharmacol 1995;294:737-42.
31. Wang Y, Mathews WR, Guido DM, Jaeschke H. The 21-aminosteroid tirilazad mesylate protects against liver injury via membrane stabilization not inhibition of lipid peroxidation. J Pharmacol Exp Ther 1996;277:714-20.
32. Audus KL, Guillot FL, Braughler JM. Evidence for 21-aminosteroid effects on the molecular packing order of hydrophobic domains in brain microvessel endothelial cells. Free Radic Biol Med 1991;11:361-72.
33. Meyer RJ, Juarez RA, Holden WE. 21-Aminosteroids protect endothelial cells against injury by neutrophils. Am Rev Resp Dis 1992;145:A571.
34. Gadaleta D, Verma M, Davis JM. Inhibition of neutrophil leukotriene generation by the 21-aminosteroid, U-74389F. J Surg Res 1994;57:233-8.
35. Shenkar R, Abraham E. Effects of treatment with the 21-aminosteroid, U74389F, on pulmonary cytokine expression following hemorrhage and resuscitation. Crit Care Med 1995;23: 132-8.
36. Hendry PJ, Anstadt MP, Plunkett MD, Amato MT, Menius JA, Lowe JE. Improved donor myocardial recovery with a new lazaroid lipid antiperoxidant in the isolated canine heart. J Heart Lung Transplant 1992;11:636-45.
37. Carrea FP, Lesnefsky EJ, Kaiser DG, Horwitz LD. The lazaroid U74006F, a 21-aminosteroid inhibitor of lipid peroxidation, attenuates myocardial injury from ischemia and reperfusion. J Cardiovasc Pharmacol 1992;20:230-5.
38. Salem YH, Dulchavsky SA, Dutta S, Diebel LN. Effect of inhibition of lipid peroxydation on myocardial oxidant damage. J Surg Res 1994;56:606-10.
39. Kong Y, Lesnefsky J, Ye J, Horwitz LD. Prevention of lipid peroxidation does not prevent oxidant-induced myocardial contractile dysfunction. Am J Physiol 1994;267:H2371-7.
40. Holzgrefe HH, Buchanan LV, Gibson JK. Effects of U74006F, a novel inhibitor of lipid peroxidation, in stunned reperfused canine myocardium. J Cardiovasc Pharmacol 1990; 18:239-48.
41. Levitt MA, Sievers RE, Wolfe CL. Reduction of infarct size during myocardial ischemia and reperfusion by lazaroid U-74500A: a nonglucocorticoid 21-aminosteroid. J Cardiovasc Pharmacol 1994;23:136-40.
42. Nediani C, Perna AM, Liguori P, et al. Beneficial effects of the 21-aminosteroid U74389G on the ischemia-reperfusion damage in pig hearts. J Mol Cell Cardiol 1997;29:2825-35.
43. Ovize M, de Lorgelil M, Ovize A, Ciavatti M, Delaye J, Renaud S. U74006F, a novel 21-aminosteroid, inhibits in vivo lipid peroxidation but fails to limit infarct size in a canine model of myocardial ischemia reperfusion. Am Heart J 1991;122:681-9.
44. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 1985;57:84-95.
45. Pfeffer MA, Pfeffer JM, Lamas GA. Development and prevention of congestive heart failure following myocardial infarction. Circulation 1993;67(suppl 4):120-5.
46. Squadrito F, Altavilla D, Ammendolia L, et al. Improved survival and reversal of endothelial dysfunction by the 21-aminosteroid, U-74389G in splanchnic ischemia-reperfusion injury in the rat. Br J Pharmacol 1995;115:395-400.
47. Saldanha C, Hearse DJ. Coronary vascular responsiveness to 5-hydroxytryptamine before and after infusion of hyperkalemic crystalloid cardioplegic solution in the rat hearts. J Thorac Cardiovasc Surg 1989;98:783-7.
48. Cartier R, Dagenais F, Hollmann C, Carrier M, Pelletier L-C. The role of preservation solutions in coronary endothelial damage during cold storage. Transplantation 1993;56:997-1000.